MENA Vaccine Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32

1
MENA Vaccine Market Research and Forecast Report
2024-2032

• Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group

• International Market Analysis Research and
  Consulting Group is a leading adviser on
  management strategy and market research
  worldwide. We partner with clients in all regions
  and industry verticals to identify their
  highest-value opportunities, address their most
  critical challenges, and transform their
  businesses.
• IMARCs information products include major
  market, scientific, economic and technological
  developments for business leaders in
  pharmaceutical, industrial, and high technology
  organizations. Market forecasts and industry
  analysis for biotechnology, advanced materials,
  chemicals, food and beverage, travel and tourism,
  nanotechnology and novel processing methods are
  at the top of the companys expertise.
• IMARCs tailored approach combines unfathomable
  insight into the dynamics of companies and
  markets with close cooperation at all levels of
  the client organization. This ensures that our
  clients achieve unmatchable competitive
  advantage, build more proficient organizations,
  and secure lasting results.

3
Report Highlight and Description

• According to the latest report by IMARC Group,
  titled "MENA Vaccine Market Industry Trends,
  Share, Size, Growth, Opportunity and Forecast
  2024-2032," the MENA vaccine market size is
  projected to exhibit a growth rate (CAGR) of 3.4
  during 2024-2032.
• A vaccine is a biological preparation that
  provides active acquired immunity to a particular
  infectious disease. It typically contains an
  agent that resembles a disease-causing
  microorganism and is often made from weakened or
  killed forms of the microbe, its toxins, or one
  of its surface proteins. The agent stimulates the
  body's immune system to recognize the agent as a
  threat, destroy it, and remember it, so that the
  immune system can more easily recognize and
  destroy any of these microorganisms that it later
  encounters. Vaccines are a fundamental component
  of modern medicine and public health, preventing
  the spread of infectious diseases that were once
  widespread and lethal, such as polio, measles,
  and smallpox. Over time, vaccination has been
  expanded to prevent a wide variety of diseases,
  ensuring better health and safety of populations.
  The development and administration of vaccines
  involve rigorous testing for safety and efficacy,
  and they are among the most cost-effective health
  interventions available. By training the immune
  system to fight pathogens, vaccines not only
  protect individuals but also contribute to "herd
  immunity," decreasing the chance of outbreaks.
• Request for a PDF sample of this report
  https//www.imarcgroup.com/mena-vaccine-market/req
  uestsample

4
Report Description

• MENA Vaccine Market Trends
• The vaccine market in the MENA region is
  experiencing significant growth driven by the
  increasing prevalence of infectious diseases and
  the ongoing need to control public health threats
  fuel the demand for effective vaccination
  programs. Diseases such as hepatitis,
  tuberculosis, and influenza remain prevalent in
  several MENA countries, pushing governments and
  healthcare providers to improve vaccination
  coverage. Besides, rising government initiatives
  and funding for immunization programs are
  propelling the market forward. Many MENA
  governments are collaborating with international
  health organizations to enhance their healthcare
  infrastructure and vaccine delivery systems,
  aiming to achieve higher immunization rates
  across their populations. Additionally, the
  recent global health crises, including the
  COVID-19 pandemic, have underscored the critical
  role of vaccines in managing health emergencies,
  leading to accelerated vaccine development and
  approval processes in the region. This urgency
  has also fostered innovation and partnerships
  among pharmaceutical companies, biotechnology
  firms, and academic institutions within the MENA
  region to develop and distribute vaccines more
  efficiently. Another trend influencing the market
  is the growing awareness and education about the
  benefits of vaccination, which is gradually
  changing public perceptions and increasing
  acceptance of vaccines across diverse demographic
  segments. Furthermore, advancements in
  biotechnology have led to the development of more
  effective and safer vaccines, enhancing public
  confidence and demand. The introduction of new
  vaccine technologies, such as mRNA and
  vector-based vaccines, offers potential for
  tackling diseases that were previously difficult
  to manage through conventional vaccination
  approaches. As the MENA region continues to focus
  on improving healthcare outcomes, the vaccine
  market is expected to expand, driven by a
  combination of health, technological, and
  governmental factors.
• View Report TOC, Figures and Tables
  https//www.imarcgroup.com/mena-vaccine-market

5
Report Segmentation

• Product Type Insights
• Multivalent Vaccine
• Monovalent Vaccine
•  
• Treatment Type Insights
• Preventive Vaccine
• Therapeutic Vaccine
• Technology Insights
• Conjugate Vaccines
• Inactivated and Subunit Vaccines
• Live Attenuated Vaccines
• Recombinant Vaccines
• Toxoid Vaccines
• Others

6
Report Segmentation

• Route of Administration Insights
• Intramuscular and Subcutaneous Administration
• Oral Administration
• Others
•  
• Patient Type Insights
• Pediatric
• Adult
• Indication Insights
• Bacterial Diseases
• Meningococcal Disease
• Pneumococcal Disease
• Diphtheria/Tetanus/Pertussis (DPT)
• Tuberculosis
• Haemophilus Influenzae (Hib)

7
Report Segmentation

• Typhoid
• Others
• Viral Diseases
• Hepatitis
• Influenza
• Human Papillomavirus (HPV)
• Measles/Mumps/Rubella (MMR)
• Rotavirus
• Herpes Zoster
• Varicella
• Japanese Encephalitis
• Rubella
• Polio
• Rabies

8
Report Segmentation

• Dengue
• Others
• Distribution Channel Insights
• Hospital Pharmacies
• Retail Pharmacies
• Institutional Sales
• Others
• End User Insights
• Hospitals
• Clinics
• Vaccination Centers
• Academic and Research Institutes
• Others

9
Report Segmentation

• Country Insights
• Saudi Arabia
• Turkey
• Israel
• United Arab Emirates
• Egypt
• Iran
• Iraq
• Qatar
• Algeria
• Kuwait
• Morocco
• Oman
• Others

10
Key Questions Answered in the Report
11
Key Questions Answered in the Report
12
Table of Contents

• 1    Preface2    Scope and Methodology    2.1  
   Objectives of the Study    2.2  
   Stakeholders    2.3    Data Sources       
  2.3.1    Primary Sources        2.3.2  
   Secondary Sources    2.4    Market Estimation 
        2.4.1    Bottom-Up Approach        2.4.2  
   Top-Down Approach    2.5    Forecasting
  Methodology3    Executive Summary4 MENA
  Vaccine Market - Introduction
• 4.1 Overview
• 4.2 Market Dynamics
• 4.3 Industry Trends
• 4.4 Competitive Intelligence
• 5 MENA Vaccine Market Landscape
• 5.1 Historical and Current Market Trends
  (2018-2023)
• 5.2 Market Forecast (2024-2032)
• 6 MENA Vaccine Market - Breakup by Product Type
• 6.1 Multivalent Vaccine
• 6.1.1 Overview
• 6.1.2 Historical and Current Market
  Trends (2018-2023)
• 6.1.3 Market Forecast (2024-2032)
• 6.2 Monovalent Vaccine
• 6.2.1 Overview
• 6.2.2 Historical and Current Market
  Trends (2018-2023)
• 6.2.3 Market Forecast (2024-2032)     
   

13
Table of Contents

• 7 MENA Vaccine Market - Breakup by Treatment
  Type
• 7.1 Preventive Vaccine
• 7.1.1 Overview
• 7.1.2 Historical and Current Market
  Trends (2018-2023)
• 7.1.3 Market Forecast (2024-2032)
• 7.2 Therapeutic Vaccine
• 7.2.1 Overview
• 7.2.2 Historical and Current Market
  Trends (2018-2023)
• 7.2.3 Market Forecast (2024-2032)
• 8 MENA Vaccine Market - Breakup by Technology
• 8.1 Conjugate Vaccines
• 8.1.1 Overview
• 8.1.2 Historical and Current Market
  Trends (2018-2023)
• 8.1.3 Market Forecast (2024-2032)
• 8.2 Inactivated and Subunit Vaccines
• 8.2.1 Overview
• 8.2.2 Historical and Current Market
  Trends (2018-2023)
• 8.2.3 Market Forecast (2024-2032)
• 8.3 Live Attenuated Vaccines

14
Partial List of Clients
15
Partial List of Clients
16
Disclaimer

• 2024 IMARC All Rights Reserved
• This Publication and all its contents unless
  otherwise mentioned are copyrighted in the name
  of International Market Analysis Research and
  Consulting (IMARC). No part of this publication
  may be reproduced, repackaged, redistributed or
  resold in whole or in any part. The publication
  may also not be used in any form or by and means
  graphic electronic or mechanical, including
  photocopying, recording, taping or by information
  storage or retrieval, or by any other form,
  without the express consent of International
  Market Analysis Research and Consulting (IMARC).
• Disclaimer All contents and data of this
  publication, including forecasts, data analysis
  and opinion have been based on information and
  sources believed to be accurate and reliable at
  the time of publishing. International Market
  Analysis Research and Consulting makes no
  representation of warranty of any kind as to the
  accuracy or completeness of any Information
  provided. IMARC accepts no liability whatsoever
  for any loss or damage resulting from opinion,
  errors or inaccuracies if any found this
  publication.
• IMARC, IMARC Group and Global Therapy Insight
  Series are registered trademarks of International
  Market Analysis Research and Consulting. All
  other trademarks used in this publication are
  registered trademarks of their respective
  companies.

17
Contact Us
Visit us at
https//www.imarcgroup.com
1-631-791-1145
sales_at_imarcgroup.com
Stay With Us